Standardization and Validation of Immunoassays

Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

Volumn , Issue , 2011, Pages 233-242

  Kramer, Daniel ^a  

^a MERCK KGAA   (Germany)

Author keywords

Assay standardization and validation and immunoassay standardization and validation; Specificity cut point, percentage inhibition at or above, sample, confirmed positive; Tiered testing approach, assessment of immunogenicity of biopharmaceutical

Indexed keywords

EID: 80052700331     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118075685.ch13     Document Type: Chapter

References (7)

1. Neumann, T.A., Foote, M. ( 2000 ). Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis . Cytokines Cell Mol Ther, 6, 47-56 .
2. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B., Mayeux, P. ( 2002 ). Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin . N Engl J Med, 346, 469-475 .
3. Mire-Sluis, A.R., Barrett, Y.C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., Swanson, S.J., Taniguchi, G., Wierda, D., Zuckerman, L.A. ( 2004 ). Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products . J Immunol Meth, 289, 1-16 .
4. Shankar, G ., Devanarayan, V., Amaravadi, L., et al. ( 2008 ). Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products . J Pharm Biomed Anal, 48 ( 5 ), 1267-1281 .
5. Koren, E., Smith, H.W., Shores, E., Shankar, G., Finco-Kent, D., Rup, B., Barrett, Y.C., Devanarayan, V., Gorovits, B., Gupta, S., Parish, T., Quarmby, V., Moxness, M., Swanson, S.J., Taniguchi, G., Zuckerman, L.A., Stebbins, C.C., Mire-Sluis, A. ( 2008 ). Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products . J Immunol Methods, 333 ( 1-2 ), 1-9 .
6. Ponce, R., Abad, L., Amaravadi, L., et al. ( 2009 ). Immunogenicity of biologically-derived therapeutics : assessment and interpretation of non-clinical safety studies . Regul Toxicol Pharmacol, 54, 164-182 .
7. Gupta, S., Indelicato, S.R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A.R., Richards, S.M., Rup, B., Shores, E., Swanson, S.J., Wakshull, E. ( 2007 ). Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics . J Immunol Methods, 321, 1-18 .